The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma.
Saved in:
| Title: | The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. |
|---|---|
| Authors: | Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Feliu I; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Maillo A; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Moreno H; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain., Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Aldaz P; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Bocanegra A; Oncoimmunology Group, Navarrabiomed, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Lecanda F; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain., Fernandez-Irigoyen J; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Proteomics Platform, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Santamaria E; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Clinical Neuroproteomics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Larrayoz IM; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain; Pre-departmental Nursing Unit, University of La Rioja (UR), Logroño, La Rioja, Spain., Gomez-Cabrero D; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia., Wellbrock C; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain., Vicent S; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain., Arozarena I; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: iarozarm@navarra.es. |
| Source: | The Journal of investigative dermatology [J Invest Dermatol] 2023 Feb; Vol. 143 (2), pp. 305-316.e5. Date of Electronic Publication: 2022 Sep 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36058299 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lasheras-Otero+I%22">Lasheras-Otero I</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Feliu+I%22">Feliu I</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Maillo+A%22">Maillo A</searchLink>; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+H%22">Moreno H</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Redondo-Muñoz+M%22">Redondo-Muñoz M</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Aldaz+P%22">Aldaz P</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Bocanegra+A%22">Bocanegra A</searchLink>; Oncoimmunology Group, Navarrabiomed, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Olias-Arjona+A%22">Olias-Arjona A</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lecanda+F%22">Lecanda F</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernandez-Irigoyen+J%22">Fernandez-Irigoyen J</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Proteomics Platform, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Santamaria+E%22">Santamaria E</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Clinical Neuroproteomics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+IM%22">Larrayoz IM</searchLink>; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain; Pre-departmental Nursing Unit, University of La Rioja (UR), Logroño, La Rioja, Spain.<br /><searchLink fieldCode="AU" term="%22Gomez-Cabrero+D%22">Gomez-Cabrero D</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Wellbrock+C%22">Wellbrock C</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Vicent+S%22">Vicent S</searchLink>; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arozarena+I%22">Arozarena I</searchLink>; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: iarozarm@navarra.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220426720%22">The Journal of investigative dermatology</searchLink> [J Invest Dermatol] 2023 Feb; Vol. 143 (2), pp. 305-316.e5. <i>Date of Electronic Publication: </i>2022 Sep 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0426720 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-1747 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022202X%22">0022202X </searchLink><i>NLM ISO Abbreviation: </i>J Invest Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36058299 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jid.2022.08.038 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 305 Titles: – TitleFull: The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lasheras-Otero I – PersonEntity: Name: NameFull: Feliu I – PersonEntity: Name: NameFull: Maillo A – PersonEntity: Name: NameFull: Moreno H – PersonEntity: Name: NameFull: Redondo-Muñoz M – PersonEntity: Name: NameFull: Aldaz P – PersonEntity: Name: NameFull: Bocanegra A – PersonEntity: Name: NameFull: Olias-Arjona A – PersonEntity: Name: NameFull: Lecanda F – PersonEntity: Name: NameFull: Fernandez-Irigoyen J – PersonEntity: Name: NameFull: Santamaria E – PersonEntity: Name: NameFull: Larrayoz IM – PersonEntity: Name: NameFull: Gomez-Cabrero D – PersonEntity: Name: NameFull: Wellbrock C – PersonEntity: Name: NameFull: Vicent S – PersonEntity: Name: NameFull: Arozarena I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1523-1747 Numbering: – Type: volume Value: 143 – Type: issue Value: 2 Titles: – TitleFull: The Journal of investigative dermatology Type: main |
| ResultId | 1 |